Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-021670
Filing Date
2020-11-16
Accepted
2020-11-16 16:05:29
Documents
56
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 453768
2 ex31-1.htm EX-31.1 11847
3 ex31-2.htm EX-31.2 11877
4 ex32-1.htm EX-32.1 4839
5 ex32-2.htm EX-32.2 4845
  Complete submission text file 0001493152-20-021670.txt   2745906

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE codx-20200930.xml EX-101.INS 383596
7 XBRL SCHEMA FILE codx-20200930.xsd EX-101.SCH 37043
8 XBRL CALCULATION FILE codx-20200930_cal.xml EX-101.CAL 48373
9 XBRL DEFINITION FILE codx-20200930_def.xml EX-101.DEF 87467
10 XBRL LABEL FILE codx-20200930_lab.xml EX-101.LAB 284804
11 XBRL PRESENTATION FILE codx-20200930_pre.xml EX-101.PRE 201849
Mailing Address 4049 SOUTH HIGHLAND DRIVE SALT LAKE CITY UT 84124
Business Address 4049 SOUTH HIGHLAND DRIVE SALT LAKE CITY UT 84124 8012789769
Co-Diagnostics, Inc. (Filer) CIK: 0001692415 (see all company filings)

EIN.: 462609396 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38148 | Film No.: 201316753
SIC: 3841 Surgical & Medical Instruments & Apparatus